liver utilization

Analysis of 415 DCD Maastricht III livers over an 11-year period in Switzerland showed that 249 were transplanted, with 158 performed at the study institution. One-year patient survival and [...]

This study validates the use of flavin mononucleotide (FMN) levels in perfusate during hypothermic oxygenated machine perfusion (HOPE) to predict liver graft outcomes. FMN levels were found to [...]

This study reveals significant variability in DCD liver utilization rates across countries, with acceptance rates ranging from 18.9% to 74.2%. Nations with more widespread adoption of machine [...]